Characterizing PFAS hazards and risks: a human population-based in vitro cardiotoxicity assessment strategy

Table 1 Donor identification and characteristics of iPSC-derived cardiomyocytes used in this study. Additional details can be found in Table S1

Cell Line ID	Source	Sex	Ancestral Background	Batch #	Catalog Number	Lot #
1434	CDI	Female	Mixed African American/ European	1,5,6	CMC-100-010-001	105,008
1565	FDA	Male	Mixed African American/ European	5	DDP-CMC-1 × 01565.104	101,514
30,171	CIRM	Female	European	3	CW30171HH1	101,998
1309	CDI			2	DDP-CMC-1 × 103,046	103,046
1531	FDA			2	DDP-CMC-1 × 101,317	101,317
1368	NHLBI			3	DDP-CMC-0.5 × 01368.716	1368.716
30,145	CIRM			4	CW30145AA1	102,118
1392	NHLBI	Male		1	DDP-CMC-0.5 × 01392.734	1392.734
1518	FDA	Male		6	DDP-CMC-1 × 101,421	101,421
1516	FDA	Female	African American	6	DDP-CMC-1 × 01516.102	102,177
1083	NHLBI	Female		1	DDP-CMC-0.5 × 01083.758	1083.758
1535	FDA	Male		3	DDP-CMC-1 × 01535.102	102,176
11,235	CDI			5	DDP-CMC-1 × 11235.106	102,328
1118	NHLBI			4	DDP-CMC-0.5 × 01118.704	1118.704
20,084	CDI	Male	Hispanic/ Latino	2	DDP-CMC-1 × 102,668	102,668
20,032	CIRM	Male	Asian	4	CW20032AA1	102,500

ISSN: 1479-7364